Uncategorized
Unavoidable pressure injury during COVID-19 Crisis
A Position Paper from the National Pressure Injury Advisory Panel https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/Unavoidable_in_COVID_Pandemi.pdf
Protected:
This content is password protected. To view it please enter your password below: Password:
Exciting changes to the American Nurse Today Website!
The American Nurse Today team is excited to announce several changes to our site, all of which are intended to enhance your experience. (more…)
Champion Launches Premier Treatment Recliner for use in Oncology and Infusion Therapy
ELKHART, Ind. – The Alō Infusion Recliner is the newest seating selection by premier medical seating company, Champion Manufacturing Inc. Widely known for their…
Vaping: 450 illnesses, 3 deaths
By Julie Cullen, Managing Editor, American Nurse Today E-cigarettes and vapes were supposed to a safer alternative for smokers. Rather than inhaling the toxic…
Using blame-free feedback to guide preceptee growth
Just Culture principles can help preceptors make better decisions. Takeaways Use open communication to avoid attributing error to the incorrect cause. Apply the Just…
Processing trauma: 5 suggestions
How can nurses and other healthcare professionals support their patients in the aftermath of a national tragedy? An individual might not be directly involved…
Nursing considerations for procedural sedation and analgesia: Part 2
This second in a two-part series reviews sedation implementation and monitoring. Takeaways: Signs and symptoms of airway obstruction during procedural sedation include increased respiratory…
FDA approves new treatment for VAP
On June 3, the FDA approved a new indication for Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial…
FDA approves treatment for episodic cluster headache
On June 4, the FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults. (more…)
FDA approves first PI3K inhibitor for breast cancer
On May 24, the FDA approved Piqray (alpelisib) tablets, to be used in combination with fulvestrant, to treat postmenopausal women, and men, with hormone…
Unavoidable pressure injury during COVID-19 Crisis
A Position Paper from the National Pressure Injury Advisory Panel https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/Unavoidable_in_COVID_Pandemi.pdf
Protected:
This content is password protected. To view it please enter your password below: Password:
Exciting changes to the American Nurse Today Website!
The American Nurse Today team is excited to announce several changes to our site, all of which are intended to enhance your…
Champion Launches Premier Treatment Recliner for use in Oncology and Infusion Therapy
ELKHART, Ind. – The Alō Infusion Recliner is the newest seating selection by premier medical seating company, Champion Manufacturing Inc. Widely known…
Vaping: 450 illnesses, 3 deaths
By Julie Cullen, Managing Editor, American Nurse Today E-cigarettes and vapes were supposed to a safer alternative for smokers. Rather than inhaling…
Using blame-free feedback to guide preceptee growth
Just Culture principles can help preceptors make better decisions. Takeaways Use open communication to avoid attributing error to the incorrect cause. Apply…
Processing trauma: 5 suggestions
How can nurses and other healthcare professionals support their patients in the aftermath of a national tragedy? An individual might not be…
Nursing considerations for procedural sedation and analgesia: Part 2
This second in a two-part series reviews sedation implementation and monitoring. Takeaways: Signs and symptoms of airway obstruction during procedural sedation include…
FDA approves new treatment for VAP
On June 3, the FDA approved a new indication for Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and…
FDA approves treatment for episodic cluster headache
On June 4, the FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults. (more…)
FDA approves first PI3K inhibitor for breast cancer
On May 24, the FDA approved Piqray (alpelisib) tablets, to be used in combination with fulvestrant, to treat postmenopausal women, and men,…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.